{"model_name":"Combination of Peri- and Intratumoral Radiomic Features on Baseline CT Scans Predicts Response to Chemotherapy in Lung Adenocarcinoma","content_code":["CT - Computed Tomography","BQ - Biomarkers/Quantitative Imaging","OI - Oncological Imaging"],"medical_task":"Predict response to chemotherapy in non-small cell lung cancer (NSCLC) using radiomic features extracted from CT scans.","date_created":"2019-03-20","license":"Copyright 2019 by the Radiological Society of North America, Inc.","funding":"Supported by the U.S. Department of Defense, the National Cancer Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Center for Research Resources, the Ohio Third Frontier Technology Validation Fund, the Wallace H. Coulter Foundation Program, and the Clinical and Translational Science Award Program at Case Western Reserve University.","use_case":["Prognosis","Risk assessment","Detection"],"users":["Researcher","Subspecialist diagnostic radiologist"],"results":[{"result_name":"Training Set AUC","result_metric":"AUC","result_value":"0.82 Â± 0.09","result_decision_threshold":"NA","result_description":"Achieved a mean maximum AUC of 0.82 in the training set using radiomic features.","result_subset_data":"Training set with 53 patients, 26 responders and 27 nonresponders"},{"result_name":"Independent Testing Set AUC","result_metric":"AUC","result_value":"0.77","result_decision_threshold":"NA","result_description":"The independent testing set showed an AUC of 0.77.","result_subset_data":"Validation set with 72 patients, 38 responders and 34 nonresponders"},{"result_name":"Time to Progression (TTP)","result_metric":"Hazard Ratio (HR)","result_value":"2.8; 95% CI: 1.95, 4.00","result_decision_threshold":"P < .0001","result_description":"Radiomics signature significantly associated with TTP.","result_subset_data":"Training set patients stratified into high-risk or low-risk groups"},{"result_name":"Overall Survival (OS)","result_metric":"Hazard Ratio (HR)","result_value":"2.35; 95% CI: 1.41, 3.94","result_decision_threshold":"P = .0011","result_description":"Radiomics signature significantly associated with OS.","result_subset_data":"Training set"},{"result_name":"Decision Curve Analysis","result_metric":"Net benefit","result_value":"Higher than clinical models","result_decision_threshold":"Different threshold probabilities","result_description":"Radiomics signature showed higher net benefit in predicting high-risk patients.","result_subset_data":"Patients in the training set"}],"caveats":"The cohort sample sizes were small, which limited stratified analyses. Variability in imaging acquisition protocols poses a challenge. Single-institution design limits generalizability. Radiomic features are dependent on manual nodule annotation.","model_code_availability":"NA","sustainability":"NA","time_to_train":"NA","time_to_inference":"NA","hardware_requirements":"NA","model_architecture":"Machine learning classifier using quadratic discriminant analysis with radiomic texture features extracted from intra- and peritumoral regions on CT images."}